CORD-19:2008f024274c53b0de1276f4047a6a641813fd98 / 231554-231647 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/2008f024274c53b0de1276f4047a6a641813fd98","sourcedb":"CORD-19","sourceid":"2008f024274c53b0de1276f4047a6a641813fd98","text":"A skin test (prick and intradermal) to piperacillin/tazobactam at 4.5mg/ml was also negative.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T19196","span":{"begin":0,"end":93},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T19196","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T397","span":{"begin":0,"end":93},"obj":"Sentence"}],"attributes":[{"subj":"T397","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T2116","span":{"begin":75,"end":78},"obj":"Disease"}],"attributes":[{"id":"A2116","pred":"mondo_id","subj":"T2116","obj":"http://purl.obolibrary.org/obo/MONDO_0010518"},{"subj":"T2116","pred":"source","obj":"CORD-19-PD-MONDO"}]},{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T469","span":{"begin":2,"end":6},"obj":"Body_part"}],"attributes":[{"id":"A469","pred":"uberon_id","subj":"T469","obj":"http://purl.obolibrary.org/obo/UBERON_0000014"},{"subj":"T469","pred":"source","obj":"CORD-19-PD-UBERON"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#93ecdc","default":true},{"id":"CORD-19_Custom_license_subset","color":"#ecc293"},{"id":"CORD-19-PD-MONDO","color":"#a893ec"},{"id":"CORD-19-PD-UBERON","color":"#97ec93"}]}]}}